Fed Rate-Hike Fears Spike as Economists Turn Hawkish and New Tariffs Loom

A Reuters poll of 104 economists shows rising odds of a 2026 Fed rate hike as oil prices surge, the U.S. prepares fresh Section 301 tariffs on dozens of countries, GM raises its profit guidance after a strong Q2, and Novo Nordisk sues Eli Lilly over weight-loss drug ad claims. In this episode: • Reuters poll shows economists see rising risk of a Federal Reserve rate hike — https://news.google.com/rss/articles/CBMiugFBVV95cUxNbV84YkM0QzhTaXRsOEtPMjNQX3RvVnBaNmZtQ1dTalN2bkRmczlkOTViLVAzRTJRYjVuSi1RNlNXQ2M4dW0tN3FPNk9BRGQxeGtLc3dteklTblBWN3VPemVEQWtOaTVkOVpBRDdNenZBQWtzX1FiQ2lZdkRodWtqamxXTks2eFQzZkMwcW5CejdVem9ESU9HNFQ1YkZrUXBGa2dpX1lKcGx0WXN2STJVanMyUFRvVFNsZWc?oc=5 • U.S. Trade Representative signals new tariffs on dozens of countries are coming soon — https://www.cnbc.com/2026/07/21/trump-trade-tariffs-greer-section-301.html • General Motors beats Q2 expectations and raises full-year profit guidance — https://www.cnbc.com/2026/07/21/general-motors-gm-earnings-q2-2026.html • Novo Nordisk sues Eli Lilly over competitive GLP-1 weight-loss drug ads — https://www.cnbc.com/2026/07/21/novo-nordisk-sues-eli-lilly-glp-1-ads.html